Actively Recruiting

All Genders
Healthy Volunteers
NCT02696135

The Chinese Hypertrophic Cardiomyopathy Study(CHCS)

Led by China National Center for Cardiovascular Diseases · Updated on 2018-03-27

3000

Participants Needed

1

Research Sites

927 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Hypertrophic cardiomyopathy (HCM) is one of the most common inherited cardiac diseases, with a prevalence of ∼0.2%. Sudden cardiac death (SCD), heart failure and stroke are the major poor outcomes of HCM. Although about half of the patients were found to be caused by mutations mainly located in genes encoding sarcomere proteins, the causes in a significant proportion of patients with HCM are still unknown. Even in the patients with sarcomere mutations, the molecular pathways that eventually lead to cardiac hypertrophy are remained to be revealed. Furthermore, HCM presents with significant heterogeneity. SCD risk stratification and prevention by ICD are necessary. However, the strategy of SCD risk stratification recommended by the 2011 ACCF/AHA and 2014 ESC guidelines were based mainly on the evidence derived from American and European countries. The accuracy of these guidelines in Chines patients with HCM was not evaluated yet.

CONDITIONS

Official Title

The Chinese Hypertrophic Cardiomyopathy Study(CHCS)

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with hypertrophic cardiomyopathy by unexplained maximal left ventricle wall thickness of 15 mm or more on echocardiography or cardiac MRI
  • Or wall thickness of 13 mm or more if there is a family history of hypertrophic cardiomyopathy
Not Eligible

You will not qualify if you...

  • Presence of other cardiac or systemic diseases that can cause similar heart muscle thickening

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Fuwai hospital

Beijing, Beijing Municipality, China, 100037

Actively Recruiting

Loading map...

Research Team

S

Song Lei, MD.&ph.D

CONTACT

S

Song Lei, MD.&ph.D

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Chinese Hypertrophic Cardiomyopathy Study(CHCS) | DecenTrialz